INTERNATIONAL REFERENCE PREPARATION OF HUMAN CHORIONIC GONADOTROPHIN FOR IMMUNOASSAY: POTENCY ESTIMATES IN VARIOUS BIOASSAY AND PROTEIN BINDING ASSAY SYSTEMS; AND INTERNATIONAL REFERENCE PREPARATIONS OF THE α AND β SUBUNITS OF HUMAN CHORIONIC GONADOTROPHIN FOR IMMUNOASSAY
The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second batch of ampoules (HCG 75/589) prepared identically from the same HCG preparation, are described. A collaborative study of these materials w...
Saved in:
Published in | Journal of endocrinology Vol. 84; no. 2; pp. 295 - 310 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
BioScientifica
01.02.1980
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second batch of ampoules (HCG 75/589) prepared identically from the same HCG preparation, are described. A collaborative study of these materials was carried out by 11 laboratories in eight countries, using different bioassay and immunoassay methods. Using the various in-vivo and in-vitro bioassays and receptor assays, the mean log potency estimates for each method within each laboratory of the HCG content of ampoules of the IRP, in terms of the Second International Standard of Human Chorionic Gonadotrophin for Bioassay (IS), were homogeneous and gave an overall weighted geometric mean (95% confidence limits) of 650 (632–669) International Units (i.u.)/ampoule. There was considerable heterogeneity of potency estimates of the IRP in terms of the IS both within and between many of the immunoassay systems (reflecting the impurity of the IS), and hence attempts to calibrate the IRP with immunoassay systems of different specificities were invalid. Immunoassay estimates of the HCG content of preparations of serum and urine, in terms of the IRP, showed considerable heterogeneity between assay systems (although the degree of this heterogeneity was no greater than that observed using the IS as standard), but the ranking order between preparations was consistent. Confirmation was obtained that contamination of the IRP with HCG-α and HCG-β subunits was insignificant. Accelerated degradation studies of the IRP stored at increased temperatures suggested that its stability under normal storage conditions would be satisfactory. It was agreed that the IRP was suitable to serve as an international reference preparation for immunoassay, and it was assigned a unitage of 650 i.u./ampoule on the basis of bioassay calibration. Since the ampoules of HCG (75/589) did not differ significantly from the IRP in any of the assay systems studied, it appeared to be equally suitable as a reference preparation. The International Reference Preparations of the α and β Subunits of Human Chorionic Gonadotrophin for Immunoassay are also described. |
---|---|
AbstractList | The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second batch of ampoules (HCG 75/589) prepared identically from the same HCG preparation, are described. A collaborative study of these materials was carried out by 11 laboratories in eight countries, using different bioassay and immunoassay methods. Using the various in-vivo and in-vitro bioassays and receptor assays, the mean log potency estimates for each method within each laboratory of the HCG content of ampoules of the IRP, in terms of the Second International Standard of Human Chorionic Gonadotrophin for Bioassay (IS), were homogeneous and gave an overall weighted geometric mean (95% confidence limits) of 650 (632–669) International Units (i.u.)/ampoule. There was considerable heterogeneity of potency estimates of the IRP in terms of the IS both within and between many of the immunoassay systems (reflecting the impurity of the IS), and hence attempts to calibrate the IRP with immunoassay systems of different specificities were invalid. Immunoassay estimates of the HCG content of preparations of serum and urine, in terms of the IRP, showed considerable heterogeneity between assay systems (although the degree of this heterogeneity was no greater than that observed using the IS as standard), but the ranking order between preparations was consistent. Confirmation was obtained that contamination of the IRP with HCG-α and HCG-β subunits was insignificant. Accelerated degradation studies of the IRP stored at increased temperatures suggested that its stability under normal storage conditions would be satisfactory. It was agreed that the IRP was suitable to serve as an international reference preparation for immunoassay, and it was assigned a unitage of 650 i.u./ampoule on the basis of bioassay calibration. Since the ampoules of HCG (75/589) did not differ significantly from the IRP in any of the assay systems studied, it appeared to be equally suitable as a reference preparation. The International Reference Preparations of the α and β Subunits of Human Chorionic Gonadotrophin for Immunoassay are also described. The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second batch of ampoules (HCG 75/589) prepared identically from the same HCG preparation, are described. A collaborative study of these materials was carried out by 11 laboratories in eight countries, using different bioassay and immunoassay methods. Using the various in-vivo and in-vitro bioassays and receptor assays, the mean log potency estimates for each method within each laboratory of the HCG content of ampoules of the IRP, in terms of the Second International Standard of Human Chorionic Gonadotrophin for Bioassay (IS), were homogeneous and gave an overall weighted geometric mean (95% confidence limits) of 650 (632–669) International Units (i.u.)/ampoule. There was considerable heterogeneity of potency estimates of the IRP in terms of the IS both within and between many of the immunoassay systems (reflecting the impurity of the IS), and hence attempts to calibrate the IRP with immunoassay systems of different specificities were invalid. Immunoassay estimates of the HCG content of preparations of serum and urine, in terms of the IRP, showed considerable heterogeneity between assay systems (although the degree of this heterogeneity was no greater than that observed using the IS as standard), but the ranking order between preparations was consistent. Confirmation was obtained that contamination of the IRP with HCG-α and HCG-β subunits was insignificant. Accelerated degradation studies of the IRP stored at increased temperatures suggested that its stability under normal storage conditions would be satisfactory. It was agreed that the IRP was suitable to serve as an international reference preparation for immunoassay, and it was assigned a unitage of 650 i.u./ampoule on the basis of bioassay calibration. Since the ampoules of HCG (75/589) did not differ significantly from the IRP in any of the assay systems studied, it appeared to be equally suitable as a reference preparation. The International Reference Preparations of the α and β Subunits of Human Chorionic Gonadotrophin for Immunoassay are also described. The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second batch of ampoules (HCG 75/589) prepared identically from the same HCG preparation, are described. A collaborative study of these materials was carried out by 11 laboratories in eight countries, using different bioassay and immunoassay methods. Using the various in-vivo and in-vitro bioassays and receptor assays, the mean log potency estimates for each method within each laboratory of the HCG content of ampoules of the IRP, in terms of the Second International Standard of Human Chorionic Gonadotrophin for Bioassay (IS), were homogeneous and gave an overall weighted geometric mean (95% confidence limits) of 650 (632–669) International Units (i.u.)/ampoule. There was considerable heterogeneity of potency estimates of the IRP in terms of the IS both within and between many of the immunoassay systems (reflecting the impurity of the IS), and hence attempts to calibrate the IRP with immunoassay systems of different specificities were invalid. Immunoassay estimates of the HCG content of preparations of serum and urine, in terms of the IRP, showed considerable heterogeneity between assay systems (although the degree of this heterogeneity was no greater than that observed using the IS as standard), but the ranking order between preparations was consistent. Confirmation was obtained that contamination of the IRP with HCG-α and HCG-β subunits was insignificant. Accelerated degradation studies of the IRP stored at increased temperatures suggested that its stability under normal storage conditions would be satisfactory. It was agreed that the IRP was suitable to serve as an international reference preparation for immunoassay, and it was assigned a unitage of 650 i.u./ampoule on the basis of bioassay calibration. Since the ampoules of HCG (75/589) did not differ significantly from the IRP in any of the assay systems studied, it appeared to be equally suitable as a reference preparation. The International Reference Preparations of the α and β Subunits of Human Chorionic Gonadotrophin for Immunoassay are also described. |
Author | STORRING, P. L GAINES-DAS, ROSE E BANGHAM, D. R |
Author_xml | – sequence: 1 givenname: P. L surname: STORRING fullname: STORRING, P. L – sequence: 2 givenname: ROSE E surname: GAINES-DAS fullname: GAINES-DAS, ROSE E – sequence: 3 givenname: D. R surname: BANGHAM fullname: BANGHAM, D. R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/6767800$$D View this record in MEDLINE/PubMed |
BookMark | eNqVks2O0zAUhQ0aNHQGNkgskbxil-I4P06YlZu6jaXGqeIEqasoPw6TUdsMSSvEY808yDwTnqZigQSCleV7vnt8JJ8rcLHv9gqA9yaami4hn-46NUVT5NkI-85LMDFt4huuh5wLMEEIYwMR33kNrobhDiHTMYl1CS5d4hIPocmLd1ykLBE05bGgK5iwBUuYCBhcJ2xNk9McxgsYZhEVMAjjRA94AJcan8dpEq9DLuAiTiCPokzEVEq6-QzXcapdNpDJlEc0ZRJq6gvVy5mEMz5ikIq5fkejWpxxMediCUdFbmTKInlzQv4honzOmIYMPj2cVp4eocxmmeCp_O_0b8CrptgO6u35vAbZgqVBaKziJQ_oyiixjw-G1bikVI1tYdspsG_V-uJgC6uyrjxUWXXjF15dNzZWuParpkCOgwtsu5VvlkpZ1jX4OPre9923oxoO-a4dKrXdFnvVHYecOIiYDsEaNEaw6rth6FWT3_ftruh_5CbKnzuQ6w7kKD93QPMfzsbHcqfqX_T507Vuj_pt-_X2e9urvGy7oWrV_tA2bVX80dYa136j_x7mJzcTwLQ |
CitedBy_id | crossref_primary_10_1002_jcla_1860010115 crossref_primary_10_1016_0003_2697_91_90232_I crossref_primary_10_1016_S0303_7207_96_03941_X crossref_primary_10_3109_00365518809167499 crossref_primary_10_1038_bjp_2008_102 crossref_primary_10_1016_0022_4731_87_91017_X crossref_primary_10_1080_00365519309086911 crossref_primary_10_3109_00365519309086912 crossref_primary_10_1007_BF02214140 crossref_primary_10_1016_0002_9378_91_91461_5 crossref_primary_10_1016_j_cca_2009_10_009 crossref_primary_10_1093_clinchem_47_2_308 crossref_primary_10_1016_S0015_0282_16_46579_9 crossref_primary_10_1515_cclm_2015_0230 crossref_primary_10_1177_000456329803500402 crossref_primary_10_1373_clinchem_2009_124578 crossref_primary_10_1111_j_1471_0528_1996_tb09554_x crossref_primary_10_1016_S1472_6483_10_60956_X crossref_primary_10_1016_0003_2697_85_90557_3 crossref_primary_10_1016_S0015_0282_16_60906_8 crossref_primary_10_1111_j_1439_0272_1989_tb02433_x crossref_primary_10_5005_jp_journals_10009_1215 crossref_primary_10_1016_S0021_9258_17_37018_7 crossref_primary_10_1515_cclm_1997_35_9_693 crossref_primary_10_1016_S0140_6736_82_92304_2 crossref_primary_10_1517_17530050802558907 crossref_primary_10_1016_S0188_4409_01_00329_0 crossref_primary_10_1186_1477_7827_7_8 crossref_primary_10_1007_BF02909335 crossref_primary_10_1016_S0303_7207_96_03942_1 crossref_primary_10_1016_S1040_8428_85_80022_6 crossref_primary_10_1080_00365519309086908 crossref_primary_10_1002__SICI_1097_0223_199812_18_12_1232__AID_PD439_3_0_CO_2_Z crossref_primary_10_1056_NEJM199912233412604 crossref_primary_10_1016_S0140_6736_82_91791_3 crossref_primary_10_1016_0009_9120_92_90030_V crossref_primary_10_1373_clinchem_2004_031922 crossref_primary_10_1016_S0140_6736_82_91408_8 crossref_primary_10_1016_S0002_9378_12_90901_1 crossref_primary_10_1088_0022_3727_43_47_474012 crossref_primary_10_1586_14737159_9_1_51 crossref_primary_10_3390_diagnostics12071670 crossref_primary_10_1006_gyno_1998_5181 crossref_primary_10_1016_S2305_0500_13_60171_2 crossref_primary_10_1006_meth_2000_0971 crossref_primary_10_1016_S0009_8981_02_00188_2 crossref_primary_10_1111_j_1439_0272_1984_tb00413_x crossref_primary_10_1016_j_mce_2006_09_004 crossref_primary_10_1016_S0015_0282_16_54130_2 crossref_primary_10_1016_S0140_6736_82_91792_5 crossref_primary_10_1177_000456328502200305 crossref_primary_10_1016_S0002_9378_84_80035_6 crossref_primary_10_1093_clinchem_43_12_2233 crossref_primary_10_1093_humupd_dml029 crossref_primary_10_1016_0009_9120_88_90002_1 crossref_primary_10_1016_S0140_6736_82_91409_X crossref_primary_10_1016_0022_1759_85_90441_7 crossref_primary_10_1016_S0889_8545_21_00120_0 crossref_primary_10_1373_49_1_144 crossref_primary_10_1016_S0015_0282_16_55232_7 crossref_primary_10_1177_000456328602300214 crossref_primary_10_3109_03009739309179322 crossref_primary_10_1016_S0015_0282_16_59135_3 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1677/joe.0.0840295 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1479-6805 |
EndPage | 310 |
ExternalDocumentID | 10_1677_joe_0_0840295 6767800 10.1677/joe.0.0840295 |
Genre | Journal Article |
GroupedDBID | - 02 08R 0R 2WC 3O- 4.4 53G 55 5GY 5RE 5VS AAFZV AAYJJ ABFLS ABLYK ABOCM ABPTK ABSGY ACNCT ACPRK ADACO ADBBV ADBIT ADDZX AENEX AFDAS AFFNX AGCAB ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P FA8 FH7 GJ GX1 H13 HZ H~9 IL9 INIJC J5H K-O KM KQ8 L7B MVM O0- O9- OHT OK1 P2P REN RHF TBS VH1 WH7 WOQ X X7M XJT ZA5 ZGI ZXP --- -~X .55 .GJ 0R~ 18M ABSQV ACGFO AFHIN AFOSN AI. BTFSW CGR CUY CVF ECM EIF F9R HF~ HZ~ NPM W8F WHG ~02 ~KM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-b292t-3f67bef43245a293dbef5232ebdc80c3df9a8ddf42e2d9cfa0552a246c91bee33 |
ISSN | 0022-0795 |
IngestDate | Fri Oct 25 00:18:02 EDT 2024 Fri Aug 23 02:24:37 EDT 2024 Sat Sep 28 08:34:15 EDT 2024 Fri Jan 15 01:59:12 EST 2021 Mon Mar 15 03:17:30 EDT 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b292t-3f67bef43245a293dbef5232ebdc80c3df9a8ddf42e2d9cfa0552a246c91bee33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 6767800 |
PQID | 75071572 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_75071572 crossref_primary_10_1677_joe_0_0840295 pubmed_primary_6767800 highwire_bioscientifica_10_1677_joe_0_0840295 bioscientifica_primary_10_1677_joe_0_0840295 |
ProviderPackageCode | RHF |
PublicationCentury | 1900 |
PublicationDate | 1980-Feb |
PublicationDateYYYYMMDD | 1980-02-01 |
PublicationDate_xml | – month: 02 year: 1980 text: 1980-Feb |
PublicationDecade | 1980 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of endocrinology |
PublicationTitleAlternate | J Endocrinol |
PublicationYear | 1980 |
Publisher | BioScientifica |
Publisher_xml | – name: BioScientifica |
SSID | ssj0015173 |
Score | 1.3837453 |
Snippet | The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second... The preparation and nature of the International Reference Preparation of Human Chorionic Gonadotrophin (HCG) for Immunoassay (IRP), as well as that of a second... |
SourceID | proquest crossref pubmed highwire bioscientifica |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 295 |
SubjectTerms | Biological Assay Chorionic Gonadotropin - analysis Chorionic Gonadotropin - standards Female Follicle Stimulating Hormone - standards Humans Immunoassay Luteinizing Hormone - standards Pregnancy Protein Binding Reference Standards Thyrotropin - standards |
Title | INTERNATIONAL REFERENCE PREPARATION OF HUMAN CHORIONIC GONADOTROPHIN FOR IMMUNOASSAY: POTENCY ESTIMATES IN VARIOUS BIOASSAY AND PROTEIN BINDING ASSAY SYSTEMS; AND INTERNATIONAL REFERENCE PREPARATIONS OF THE α AND β SUBUNITS OF HUMAN CHORIONIC GONADOTROPHIN FOR IMMUNOASSAY |
URI | http://dx.doi.org/10.1677/joe.0.0840295 http://joe.endocrinology-journals.org/content/84/2/295.abstract https://www.ncbi.nlm.nih.gov/pubmed/6767800 https://search.proquest.com/docview/75071572 |
Volume | 84 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7aIlCRQLSlIjz3QHsxNo7fhpPTuEkQjiPbqdqTZcdrCaQmFSQH-FfwQ_qbmH3YiQsRDRfLj9n12vPNzs7s7CxCb0pdK52SuLKtWnSakTqabN2WQZNMzNwozTKjfshgaPXHxsdz83xr-2wlamkxz5XJj7-uK_kfrsI94CtdJbsBZ-tK4QacA3_hCByG46143MxnG_mnfsQ8RvBbRx73PtGonv448IbSST-M4Ab89R6Qd8MkCkf9wVACM1AaBMF4GHpx7F1QF8EoTKCeC8mPk0HgJT5dZiydeVB8HEudASdkialGEZDCw85g2KV-L_4kvogTP4jp9gCU6BbNjKvoo6MT_6jTZsXYqSbF4w4YqUm88ZesGXeTaTGDrrI5nzBSpE8KDI_DqE6xRWehwtiXfEXqeXRvErm73LS5q0iRInW8Ya8vQiQKvpTQUatg66UXnfWfLCYrW1USGg3I5Xt_KoTrBcN2ZctRzVXFwfe2EwKirWoBXvYP7WSx-fEvM6KoigqW9Q06YPDVJYMqzaLnqOpSR1dxCTdUdx1Quab2bXRXgw6Y9vy98zr0CQZ5IvJCfKjIPQsVvGsU30X3REseoIf5Z55dlf-u5jCuSq293kxjw7XkMXok-I09LjR7aItM99GBN83ms8vv-BizyGcGgX10PxABJgd39hpYxTVW8QpWcXiKGRBxDUTcACIGIOIVIL7HQqBwLVAYqIRA4UqgMIAeC4HCQqAwfyIE6gMjuUUTY9pGECd8_ZMVuf6FKzHauPVP0PjUT076stg2Rc41V5vLemnZOSlpqk0zg9F8ARcmGE4kLyaOOtGL0s2coigNjWiFOykz1TS1TDOsidvOCdH1Q7QznU3JU4TpSnWDemQsYhqF1s4dyy1yvXCL0szLttlCb5uwSK94jpyU-hYATyngKVVTgacWOq5A8y9CuYJUeuMFa-hfV7hLQT3SOc9sSmaLb6lN7V3T1lrokMOxfrFA9rMNX_Uc7S77khdoZ_51QV6CXTLPXzEh-w2Nwgxw |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=INTERNATIONAL+REFERENCE+PREPARATION+OF+HUMAN+CHORIONIC+GONADOTROPHIN+FOR+IMMUNOASSAY%3A+POTENCY+ESTIMATES+IN+VARIOUS+BIOASSAY+AND+PROTEIN+BINDING+ASSAY+SYSTEMS%3B+AND+INTERNATIONAL+REFERENCE+PREPARATIONS+OF+THE+%CE%B1+AND+%CE%B2+SUBUNITS+OF+HUMAN+CHORIONIC+GONADOTROPHIN+FOR+IMMUNOASSAY&rft.jtitle=Journal+of+endocrinology&rft.au=P.+L.+STORRING&rft.au=ROSE+E.+GAINES-DAS&rft.au=D.+R.+BANGHAM&rft.date=1980-02-01&rft.pub=BioScientifica&rft.issn=0022-0795&rft.eissn=1479-6805&rft.volume=84&rft.issue=2&rft.spage=295&rft_id=info:doi/10.1677%2Fjoe.0.0840295&rft_id=info%3Apmid%2F6767800&rft.externalDBID=n%2Fa&rft.externalDocID=10.1677%2Fjoe.0.0840295 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-0795&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-0795&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-0795&client=summon |